Premium
Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer
Author(s) -
Glockzin Gabriel,
Ghali Nabil,
Lang Sven A.,
Schlitt Hans J.,
Piso Pompiliu
Publication year - 2009
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.21332
Subject(s) - medicine , hyperthermic intraperitoneal chemotherapy , cytoreductive surgery , peritoneal carcinomatosis , colorectal cancer , intraperitoneal chemotherapy , chemotherapy , surgery , cancer , oncology , ovarian cancer
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) provide a promising additional treatment option for selected patients with peritoneal carcinomatosis arising from colorectal cancer. Due to the aggressive surgery the concept is associated with a significant morbidity rate. Thus, the operative risk has to be evaluated against the background of the expected improvement of the oncological outcome. J. Surg. Oncol. 2009;100:306–310. © 2009 Wiley‐Liss, Inc.